A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The search for novel prognostic and predictive parameters in breast carcinoma is relentless. The new technological advances in gene expression profiling and in mutational analysis will hopefully prove to be clinically useful in informing the choice for the systemic therapy. For the time being, we are still relying in established immunohistochemical markers, namely estrogen and progesterone receptors, HER2 and Ki67. Advances in the harmonization of pre-analytical, analytical and interpretative variables may improve accuracy and reproducibility of the results.

Original languageEnglish
Pages (from-to)S23-S25
JournalBreast
Volume24
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Gene Expression Profiling
Progesterone Receptors
Tumor Biomarkers
Genomics
Reproducibility of Results
Estrogen Receptors
Breast Neoplasms
Phenotype
Pharmaceutical Preparations
Therapeutics

Keywords

  • Estrogen receptors
  • HER2
  • Ki67
  • Molecular profiling
  • Progesterone receptors
  • Prognostic parameters

ASJC Scopus subject areas

  • Surgery

Cite this

A bad tumor biomarker is as bad as a bad drug : The gap between genomics data and phenotype to predict response. / Viale, Giuseppe.

In: Breast, Vol. 24, 01.11.2015, p. S23-S25.

Research output: Contribution to journalArticle

@article{07e0b6174a3f443a9220ebe367cae18d,
title = "A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response",
abstract = "The search for novel prognostic and predictive parameters in breast carcinoma is relentless. The new technological advances in gene expression profiling and in mutational analysis will hopefully prove to be clinically useful in informing the choice for the systemic therapy. For the time being, we are still relying in established immunohistochemical markers, namely estrogen and progesterone receptors, HER2 and Ki67. Advances in the harmonization of pre-analytical, analytical and interpretative variables may improve accuracy and reproducibility of the results.",
keywords = "Estrogen receptors, HER2, Ki67, Molecular profiling, Progesterone receptors, Prognostic parameters",
author = "Giuseppe Viale",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.breast.2015.07.007",
language = "English",
volume = "24",
pages = "S23--S25",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - A bad tumor biomarker is as bad as a bad drug

T2 - The gap between genomics data and phenotype to predict response

AU - Viale, Giuseppe

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The search for novel prognostic and predictive parameters in breast carcinoma is relentless. The new technological advances in gene expression profiling and in mutational analysis will hopefully prove to be clinically useful in informing the choice for the systemic therapy. For the time being, we are still relying in established immunohistochemical markers, namely estrogen and progesterone receptors, HER2 and Ki67. Advances in the harmonization of pre-analytical, analytical and interpretative variables may improve accuracy and reproducibility of the results.

AB - The search for novel prognostic and predictive parameters in breast carcinoma is relentless. The new technological advances in gene expression profiling and in mutational analysis will hopefully prove to be clinically useful in informing the choice for the systemic therapy. For the time being, we are still relying in established immunohistochemical markers, namely estrogen and progesterone receptors, HER2 and Ki67. Advances in the harmonization of pre-analytical, analytical and interpretative variables may improve accuracy and reproducibility of the results.

KW - Estrogen receptors

KW - HER2

KW - Ki67

KW - Molecular profiling

KW - Progesterone receptors

KW - Prognostic parameters

UR - http://www.scopus.com/inward/record.url?scp=84948709796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948709796&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2015.07.007

DO - 10.1016/j.breast.2015.07.007

M3 - Article

C2 - 26255744

AN - SCOPUS:84948709796

VL - 24

SP - S23-S25

JO - Breast

JF - Breast

SN - 0960-9776

ER -